DC 7528Genitourinary38 CFR § 4.115bLast verified: APR 8, 2026

Malignant neoplasms of the genitourinary system — VA Rating Criteria (38 CFR DC 7528)

The VA rates Malignant neoplasms of the genitourinary system under 38 CFR 38 CFR § 4.115b, Diagnostic Code 7528, from 100% to 100% based on the frequency and functional severity of symptoms. The maximum 100% rating requires Malignant neoplasms of the genitourinary system. Related conditions in the Genitourinary body system share this rating framework.

What are the VA rating criteria for Malignant neoplasms of the genitourinary system?

100%Disability Rating

Malignant neoplasms of the genitourinary system

Malignant neoplasms of the genitourinary system
— 38 CFR 38 CFR § 4.115b, Diagnostic Code 7528 (100% tier)

Which conditions are commonly secondary to Malignant neoplasms of the genitourinary system?

Common Questions About Malignant neoplasms of the genitourinary system VA Ratings

What is the VA disability rating for Malignant neoplasms of the genitourinary system?

The VA rates Malignant neoplasms of the genitourinary system under Diagnostic Code 7528 at the following tiers: 100%. The minimum 100% rating requires: Malignant neoplasms of the genitourinary system. The maximum 100% rating requires: Malignant neoplasms of the genitourinary system.

What is Diagnostic Code 7528?

Diagnostic Code 7528 is the VA rating identifier for Malignant neoplasms of the genitourinary system within 38 CFR 38 CFR § 4.115b. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.

What is the highest rating for Malignant neoplasms of the genitourinary system?

The highest schedular rating for Malignant neoplasms of the genitourinary system under DC 7528 is 100%. This tier requires: Malignant neoplasms of the genitourinary system. Veterans who cannot secure substantially gainful employment due to Malignant neoplasms of the genitourinary system alone or in combination with other service-connected conditions may also qualify for TDIU at the 100% compensation rate under 38 CFR § 4.16.

What 38 CFR section governs Malignant neoplasms of the genitourinary system ratings?

Malignant neoplasms of the genitourinary system is rated under 38 CFR 38 CFR § 4.115b, Diagnostic Code 7528. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.

Which conditions are commonly secondary to Malignant neoplasms of the genitourinary system?

Conditions commonly secondary to Malignant neoplasms of the genitourinary system include: Chemotherapy-Induced Peripheral Neuropathy (CIPN), Chronic Fatigue / Cancer-Related Fatigue, Erectile Dysfunction (Post-Cancer Treatment), Major Depressive Disorder / Anxiety Disorder (Cancer-Related), Urinary Incontinence (Post-Prostatectomy / Post-Radiation), Urinary Incontinence / Urinary Frequency. Secondary conditions caused or aggravated by a service-connected disability are ratable under 38 CFR § 3.310. Medical nexus evidence linking the primary and secondary condition is required.

What evidence do I need to establish service connection for Malignant neoplasms of the genitourinary system?

Service connection for Malignant neoplasms of the genitourinary system requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.

Get a Personalized Rating Analysis

VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.

Discover Your Benefits